Guide
Do psychedelics affect memory and cognition?
Updated September 15, 2026 · kept current as we cover new studies
The short answer
On the evidence we have covered: a single dose of psilocybin or MDMA showed no sign of impairing working memory in healthy volunteers. Memory task accuracy was actually higher at a three-month follow-up, and EEG recordings showed lasting changes in memory-related brain activity.
The caveat is large enough that the study's own authors lead with it: there was no control group. An improvement three months after doing a demanding memory task several times cannot be separated from simply having practised it. That is why this counts as an exploratory result rather than a finding.
It is also one study, at one dose, in healthy volunteers. It says nothing about repeated use, recreational doses, other drugs, or people with psychiatric conditions.
What this page covers. Cognition after single supervised doses in healthy volunteers, plus the trials we have covered on what psychedelics are being tested to treat. Not a safety review, and not evidence about recreational or repeated use. Every claim above is drawn from the studies below, and each of those links to the original paper.
The cognition study
The direct test: working memory and EEG before dosing, days after, and three months later.
Do psychedelics harm memory?
An exploratory study of working memory after a single dose. Reassuring — but it had no control group.
What psychedelics are being tested to treat
The trials that make the cognition question worth asking in the first place.
Can a single dose of psilocybin help people quit cocaine?
A randomized controlled trial tested psilocybin plus structured psychotherapy for a disorder with no approved medications.
Can one day of an inhaled psychedelic lift treatment-resistant depression?
In a phase 2b trial across 16 European sites, 81 adults with treatment-resistant depression received up to three escalating inhaled doses of mebufotenin (GH001) or placebo on a single day. One week later, 57.5% of the drug group (23 of 40) were in remission, compared with 0% of the 41 placebo patients.
Common questions
Do psychedelics damage memory?
The study we covered found no evidence of working-memory impairment from a single dose of psilocybin or MDMA in healthy volunteers. Because it had no control group, it cannot rule impairment in or out with confidence, and it does not speak to repeated use.
Why did memory scores improve?
Nobody knows from this study. Participants completed the same demanding memory task repeatedly across three months, and with no control group, practice is a straightforward explanation that the design cannot exclude.
How many people were studied?
29 people analysed per drug, with 16 taking both after a washout period, all healthy volunteers receiving a single dose.
This is an educational summary, not medical or psychological advice, and it is not a substitute for consultation with a qualified professional. Read the full disclaimer.